Director/PDMR Shareholding
Faron Pharmaceuticals Ltd. announced that its CEO, Juho Jalkanen, subscribed to 23,656 ordinary shares at EUR 0.5 per share on March 17, 2026, as part of a rights issue. Additionally, Mr. Jalkanen acquired 4,860 ordinary shares at the same price on behalf of closely associated persons. These transactions represent a direct investment by the CEO and associated individuals into the company, signaling confidence in its future prospects.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | March 19, 2026 at 09:10:00 EET |
TURKU, FINLAND – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, announces today that Juho Jalkanen, CEO of the Company, subscribed 23,656 ordinary shares in Faron at price of EUR 0.5 per share on 17 March 2026, pursuant to the rights issue announced by the Company on 10 March 2026.
Additionally, Juho Jalkanen subscribed 4,860 ordinary shares in Faron at a price of EUR 0.5 per share on 17 March 2026 on behalf of persons closely associated.
Further details are set out in the Notification of Dealing Form below.
| 2 | Reason for notification | |
| a. | Position/Status | CEO PCA PCA PCA PCA PCA |
| b. | Initial notification/ Amendment | Initial Notification |
| c. | Reference number | 148007/7/4 |
| a. | Name | Faron Pharmaceuticals Ltd. |
| b. | LEI | 7437009H31TO1DC0EB42 |
| a. | Description of the financial instrument, type of instrument Identification Code | Share ISIN: FI4000153309 |
| b. | Nature of the transaction | Subscription |
| Price(s) per share (p) | Volume(s) | |
| EUR 0.5 EUR 0.5 EUR 0.5 EUR 0.5 EUR 0.5 EUR 0.5 | 23,796 1,377 684 1,431 684 684 | |
| d. | Aggregated information Volume Price | Transaction details (a) (1): Volume 23,796 Unit price: 0.5 EUR (2): Volume 1,377 Unit price: 0.5 EUR (1): Volume 684 Unit price: 0.5 EUR (1): Volume 1,431 Unit price: 0.5 EUR (1): Volume 684 Unit price: 0.5 EUR (1): Volume 684 Unit price: 0.5 EUR |
| f. | Venue | Nasdaq First North Growth Market |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.